EWA
FBT icon

EverSource Wealth Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

EverSource Wealth Advisors’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-62
Closed -$9.56K – 2434
2022
Q4 		$9.56K Buy
+62
New +$9.15K ﹤0.01% 1351

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

EverSource Wealth Advisors's FBT Position: Q1 2023 in Review

EverSource Wealth Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2023, closing a stake of 62 shares — an estimated $9.56K sold.

EverSource Wealth Advisors first reported a position in FBT in Q4 2022 and held it in 1 quarter. The position peaked at $9.56K in Q4 2022. 245 funds tracked by Wall St. Rank hold FBT as of Q1 2023.

  • EverSource Wealth Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2023 after selling out during the quarter.
  • EverSource Wealth Advisors sold 62 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2023, an estimated $9.56K.
  • EverSource Wealth Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2022 and held it in 1 quarter.
  • EverSource Wealth Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $9.56K in Q4 2022.
  • 245 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2023.

Based on EverSource Wealth Advisors's 13F filing for Q1 2023, filed 11 May 2023.